Integrative Genomics And Prediction Of Cardiovascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$766,820.00
Summary
Technologies that measure whole molecular systems are just beginning to reveal the complexity of living organisms and the underlying molecular networks that govern them. Cardiovascular diseases emerge out of these networks as a result of genetic and molecular perturbations. This project aims to characterize the role molecular networks play in cardiovascular disease risk as well as how they react to genetic risk factors. In doing so, it will identify potential therapeutics and personalized approa ....Technologies that measure whole molecular systems are just beginning to reveal the complexity of living organisms and the underlying molecular networks that govern them. Cardiovascular diseases emerge out of these networks as a result of genetic and molecular perturbations. This project aims to characterize the role molecular networks play in cardiovascular disease risk as well as how they react to genetic risk factors. In doing so, it will identify potential therapeutics and personalized approaches to target pathogenesis.Read moreRead less
Leveraging Genomics Strategies To Generate Adult Neurons From IPSCs And Somatic Cells
Funder
National Health and Medical Research Council
Funding Amount
$1,593,336.00
Summary
Recent advances have made it possible to derive myriad specialized human cells from stem cells or by directly reprogramming cell identity. However, these derived cells are generally arrested at a fetal developmental stage, and do not mature to function like adult cells. We will use new genomic, epigenetic, cell reprogramming, and manipulation methods to discover how to derive mature cells, aiming to generate mature neurons for use in neurobiology research, disease modeling, and drug screening.
Exploring The Role Of MicroRNA And Target Processing Variability In Cardiac Hypertrophy
Funder
National Health and Medical Research Council
Funding Amount
$605,190.00
Summary
microRNAs are gene regulators with critical roles in heart disease. How interactions between microRNAs and their messenger RNA targets change during disease is poorly understood. We hypothesise that these interactions are critically affected by altered processing of microRNAs and targets. We will thus characterise and validate such differences in healthy and diseased hearts. This will define gene regulatory changes underpinning heart disease and contribute to the search for better treatment.